期刊文献+

Mdm2和pAkt在肝细胞癌中的表达及临床意义 被引量:1

The expression and clinical significance of Mdm2 and pAkt in hepatocellular carcinoma
下载PDF
导出
摘要 目的:探讨肝细胞癌(HCC)组织中鼠双微体基因2(Mdm2)和磷酸化的丝氨酸/苏氨酸蛋白激酶(pAkt)的表达和临床意义。方法:采用免疫组织化学EliVision法测定70例HCC样本和40例癌旁组织样本中Mdm2和pAkt的表达,分析它们与临床病理特征之间的关系。结果:Mdm2在HCC中阳性率为34.3%,显著高于癌旁组织(P<0.01),其表达在肿瘤>5 cm和有淋巴结转移患者的HCC样本中显著增高(P<0.05)。pAkt在HCC中表达率为37.1%,显著高于癌旁组织(P<0.01),其表达在肿瘤大小、病理分级、TNM分期和淋巴结转移等临床病理参数上差异有统计学意义(P<0.05)。Mdm2与pAkt表达在HCC组织中呈正相关关系(r's=0.441,P<0.01)。结论:Mdm2和pAkt与HCC进展有关,有可能作为评价HCC预后的指标。 Objective:To explore the expression and clinical significance of murine double minute 2 (Mdm2) and phospho-serine/ threonine protein kinase(pAkt) in hcpatocellular carcinoma(HCC). Methods:The protein levels of Mdm2 and pAkt were detected by EliVision immunohistochemistry in 70 HCC tissue samples and 40 tissues adjacent to carcinoma correlation between their expressions and clinicopathological features was analyzed. Results:The expression postive rate of Mdm2 in HCC tissue (34.3%) was significantly higher than that in tissues adjacent to carcinoma( P 〈 0.01 ) ,its expression in tumor size more than 5 cm or lymphnode metastasis tissue significantly increased( P 〈 0.05 ). The expression postive rate of pAkt in HCC tissue (37.1%) was significantly higher than that in tissues adjacent to carcinoma( P 〈 0.01 ) ,its expression differences in different tumor size ,pathologic grade ,TNM stage and lymphnode metastasis tissue were statistical significance ( P 〈 0.05 ). The Mdm2 expression was positively related with pAkt expression in HCC tissue( r', = 0.441 ,P 〈 0.01 ). Conclusions:The expressions of Mdm2 and pAkt may be associated with the progression of HCC, which can serve as the index for evaluating the prognosis of HCC.
出处 《蚌埠医学院学报》 CAS 2013年第7期797-799,802,共4页 Journal of Bengbu Medical College
基金 安徽省自然科学基金资助项目(1208085MH170) 安徽省教育厅基金资助项目(KJ2013B147)
关键词 肝细胞癌 鼠双微体基因2 丝氨酸 苏氨酸蛋白激酶 hepatocellular carcinoma nmrine double minute 2 serine/threonine protein kinase
  • 相关文献

参考文献15

  • 1FerlayJ, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10[RJ. Lyon, France: International Agency for Research on Cancer 2010 http://globocan. iarc. fro. 被引量:1
  • 2杨红,李婕,郭嘉,张尚福.TIMP-3和mtp53在非小细胞肺癌中的表达及意义[J].中国肺癌杂志,2012,15(4):202-207. 被引量:5
  • 3Akcakanat A,Sahin A,Shaye AN,et al, Comparison of AktimTOR signaling in primary breast tumors and matched distant metastases[J]. Cancer ,2008,112(11) :2352 - 2358. 被引量:1
  • 4Liu G, Wheatley-Price P, Zhou W, et al. Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk[J]. IntJ Cancer ,2008, 122( 4) :915 -918. 被引量:1
  • 5Zhao E, Cui D, Yuan L, et al. MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis[J]. Mol Bioi Rep, 2012,39 (4) :3471 -3477. 被引量:1
  • 6Hav M,Libbrecht L,Ferdinande L,et al. MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option[J]. Virchows Arch,20ll ,458(2) :197 -203. 被引量:1
  • 7Mejia-Guerrero S, Quejada M, Gokgoz N .et al. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma[J]. Genes Chromosomes Cancer, 2010,49(6) :518 -525. 被引量:1
  • 8Zhang MF, Zhang ZY , FuJ ,et al. Correlation between expression of p53, p21 IW AFI , and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma[J].J Transl Med,2009,7: 110. 被引量:1
  • 9Yamamoto S, Tomita Y, Hoshida Y ,et al. Prognostic signifi cance of activated Akt expression in pancreatic ductal adenocarcinoma[J] . Clin Cancer Res, 2004 , 10 ( 8) : 2846 - 2850. 被引量:1
  • 10Cai Q, Deng H, Xie D, et al. Phosphorylated AKT Protein is overexpressed in Human peripheral t-celilymphomas and predicts decreased patient survival[J]. Clin Lymphoma Myeloma Leuk, 2012,12(2) :106 -112. 被引量:1

二级参考文献16

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2李爱武,易祥华,周彩存,吕梅君,徐瑛,周崧雯.p53、C-erbB-2和nm23基因表达在非小细胞肺癌中的临床意义[J].临床肿瘤学杂志,2005,10(4):346-349. 被引量:10
  • 3张丽华,侯振江.p53基因在肺癌研究中的进展[J].临床肺科杂志,2006,11(1):59-60. 被引量:18
  • 4Chen G,Gharib TG,Wang H. Protein profiles associated with survival in lung adenocarcinoma[J].Proceedings of the National Academy of Sciences(USA),2003,(23):13537-13542.doi:10.1073/pnas.2233850100. 被引量:1
  • 5Powe DG,Brough JL,Carter GI. TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma[J].British Journal of Cancer,1997,(11):1678-1683. 被引量:1
  • 6Qi JH,Ebrahem Q,Moore N. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP-3):inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2[J].Nature Medicine,2003,(04):407-415.doi:10.1038/nm846. 被引量:1
  • 7Darnton SJ,Hardie LJ,Muc RS. Tissue inhibitor of met alloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma:Loss of expression correlates with poor prognosis[J].International Journal of Cancer,2005,(03):351-358.doi:10.1002/ijc.20830. 被引量:1
  • 8Span PN,Lindberg RL,Manders P. Tissue inhibitors of metalloproteinase expression in human breast cancer:TIMP-3 is associated with adjuvant endocrine therapy success[J].Journal of Pathology,2004,(04):395-402.doi:10.1002/path.1528. 被引量:1
  • 9Celebiler Cavusoglu A,Kilic Y,Saydam S. Predicting invasive pheno-type with CDH1,CDH13,CD44,and TIMP-3 gene expression in primary breast cancer[J].Cancer Science,2009,(12):2341-2345.doi:10.1111/j.1349-7006.2009.01333.x. 被引量:1
  • 10Mino N,Takenaka K,Sonobe M. Expression of tissue inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic significance in resected non-small cell lung cancer[J].Journal of Surgical Oncology,2007,(03):250-257.doi:10.1002/jso.20663. 被引量:1

共引文献4

同被引文献38

  • 1任义,吴逸明,董海燕,魏立,吴拥军.肺癌组织中MDM2、P53蛋白的表达[J].郑州大学学报(医学版),2005,40(1):67-69. 被引量:9
  • 2高崇峰,吕有勇.胃癌组织中多种癌基因变异的观察[J].中华医学杂志,1996,76(9):671-675. 被引量:10
  • 3Tandon S, Beer H, Jones TM, et al. Immunohistochemical expression of p53 and MDM2 within head and neck squamous cell carcinoma[ J]. Clin Otolaryngol, 2006,31 ( 3 ) :247. 被引量:1
  • 4Lam KY, LO CY, Wat NM. The clinicopathological features and import ance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas[ J]. J Clin Pathol, 2001,54(6) :443 -448. 被引量:1
  • 5Wang M, Zhang Z, Zhu H, et al. A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population[ J]. Clin Cancer Res, 2008,14 ( 11 ) : 3633 - 3640. 被引量:1
  • 6Epistolato MC, Diseiglio V, Livide G, et al. p53 Arg72Pro and MDM2 309 SNPs in hereditary retinoblastoma[ J]. J Hum Genet, 2011,56 (9) :685 -686. 被引量:1
  • 7Chien WP, Wong RH, Cheng YW, et al. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non - small - cell lung cancer patients with wild - type p53 tumors[J]. Ann Surg Oncol, 2010,17(4) :1194 -1202. 被引量:1
  • 8Sharifi- Sistani N, Zartab H, Babakoohi S, et al. Immunohistochemi- cal comparison of the expression of p53 and MDM2 protein ameloblas- tomas and keratocystic odontogenic tumors[ J]. J C raniofacSurg, 2011, 22(5) :1652 - 1656. 被引量:1
  • 9Nakashima M, Kondo S, Shimizu Y, et al. Impact of MDM2 single nu- cleotide polymorphism on tumor onset in head and Beck squamous cell caxuinoala[ J ]. Acta Otolaryngol, 2008,128 (7) :808 - 813. 被引量:1
  • 10Millon R, Muller D, Schuhz I, et al. Loss of MDM2 expression in hu- man head and neck squamous cell carcinomas and elinical significance [J]. Oral Oncol, 2001,37(8) :620 -631. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部